SAN FRANCISCO, March 16, 2026 /PRNewswire/ -- Allelica, a leader in genomic risk assessment for common diseases, announced today that polygenic risk scores (PRS) have been recognized as a ...
Allelica, the global leader in multi-ancestry clinical polygenic risk score (PRS) testing, has been selected as the PRS testing collaborator for the PROACT 3 clinical trial at Mass General Brigham.
A new study links telomere length and polygenic risk scores to IPF development, highlighting genetic drivers beyond rare variants. The role of polygenic risk scores in patients with idiopathic ...
Morning Overview on MSN
Study finds 100,000 small factors can rival DNA in disease risk
Researchers have mapped how hundreds of everyday environmental and lifestyle exposures, from diet and pollution to social ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results